Robust Efficient Performance for Cell and Gene Therapy Applications
In regenerative medicine and cell therapy treatments cells are treated as the medical product replacing missing or dysfunctional patient´s cells. Cells are taken from the donor, cultivated, expanded and eventually manipulated ex-vivo before being administrated to the patient. The cells can either be autologous (where the recipient is also the donor) or allogeneic (where the donor and recipient are distinct individuals). The cells used in cell therapy can be primary cells or from cell lines. The most important cells are hematopoietic cells (T or B lymphocytes, dendritic or natural killer cells), tissue cells (skin, etc.), and stem cells isolated from bone marrow and fat tissues.
Media for Gene and Cell Therapy Processes
Customized Solutions for Unique Needs
Production-Focused Approach to Produce Your Unique Media Solutions
Perfect choice for clients who have known, desired media composition and outcome expectations. For critical raw materials you can either request specific suppliers or rely upon Sartorius’s established global network of qualified suppliers. Customized packaging, media formats, and release assays are also available upon request.
Attractive Other Media for Primary Cell-Based Processes
Sartorius Australia Pty Ltd | Food, Pharma and Lab applications IndustrySearch Trusted Supplier
Sartorius Mechatronics Australia Pty Ltd is supplying selected products direct to customers in Australia, as well as though our many Sales & Service Partners.
Sartorius is an internationally leading ...